SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-19-011632
Filing Date
2019-09-11
Accepted
2019-09-11 17:16:10
Documents
1
Period of Report
2019-09-11
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K a8-kxclinigenupdatesept2019.htm 8-K 33551
  Complete submission text file 0001628280-19-011632.txt   34555
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

IRS No.: 000000000
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 191089015
SIC: 2834 Pharmaceutical Preparations